Research & Innovation
Publications
Sprifermin for Treatment of Osteoarthritis: Recombinant Fibroblast Growth Factor 18 as a Possible Disease-Modifying Knee Osteoarthritis Drug.
PMU Authors
Martin Jakab, Tobias Kiesslich, Antje van der Zee-Neuen, Markus Ritter
All Authors
Martin Jakab, Tobias Kiesslich, Antje van der Zee-Neuen, Wirth, W, Markus Ritter
Journal association
Paracelsus Proceedings of Experimental Medicine
Abstract
We are sorry. The full text is not available.